GC MS Receives Export Approval for '10-Minute COVID-19 Diagnostic Kit'
[Asia Economy, reporter Cho Hyun] GC MS announced on August 31 that it had received export approval from the Ministry of Food and Drug Safety on August 28 for its point-of-care testing (POCT) antigen diagnostic kit for COVID-19, ‘GENEDIA W COVID-19 Ag’.
This product is an antigen diagnostic kit that uses antigen-antibody binding reactions to diagnose COVID-19 infection on-site within 10 minutes. Using nasopharyngeal and sputum samples, it allows for visual confirmation of early-stage COVID-19 infection without any additional equipment.
With this approval, GC MS can now export a total of five products: two types of antibody diagnostic kits, two types of molecular diagnostic kits, and now an antigen diagnostic kit.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military Spokesperson: "Ceasefire Was an Opportunity to Strengthen Forces... Ready to Respond to War"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
GC MS CEO Ahn Eunok stated, "We plan to build an integrated diagnostic platform for COVID-19 by adding fluorescent immunoassay products in the future."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.